Get the Stockscreener App
2.26
0.00%
0.00
Arcadia Biosciences Inc stock is traded at $2.26, with a volume of 38,840.
It is up +0.00% in the last 24 hours and down -29.60% over the past month.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
See More
Previous Close:
$2.26
Open:
$2.2901
24h Volume:
38,840
Relative Volume:
1.38
Market Cap:
$4.93M
Revenue:
$5.41M
Net Income/Loss:
$-7.08M
P/E Ratio:
-0.4096
EPS:
-5.5181
Net Cash Flow:
$-7.58M
1W Performance:
-5.83%
1M Performance:
-29.60%
6M Performance:
-48.27%
1Y Performance:
-57.12%
1-Day Range:
$2.26
$2.33
1-Week Range:
$2.16
$2.38
52-Week Range:
$1.76
$6.71
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
214-974-8921
Address
5956 SHERRY LANE, DALLAS, CA
Compare RKDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
2.26 | 4.93M | 5.41M | -7.08M | -7.58M | -5.5181 |
|
KHC
Kraft Heinz Co
|
23.20 | 26.89B | 25.16B | -4.36B | 3.63B | -3.7213 |
|
GIS
General Mills Inc
|
44.56 | 23.74B | 19.16B | 2.93B | 2.10B | 5.2819 |
|
JBS
Jbs N V
|
15.63 | 17.15B | 60.44B | 2.01B | -373.53M | 1.7874 |
|
MKC
Mccormick Co Inc
|
60.79 | 16.42B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
24.60 | 13.40B | 11.91B | 756.75M | 890.57M | 1.37 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
Why is Arcadia Biosciences Inc stock going up2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Arcadia Biosciences shares slip 13% after Roosevelt Resources terminates merger agreement - MSN
Can Arcadia Biosciences Inc disrupt its industry2025 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain InvestorsSEC Filing - TradingView
Arcadia Biosciences Executes Inducement Financing to Bolster Liquidity - TipRanks
Arcadia Biosciences Signs Multiple Financing Agreements - TradingView
Arcadia Biosciences (NASDAQ: RKDA) gets $2.1M from option exercises - Stock Titan
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds - GlobeNewswire
This wellness company cut investor option prices to bring in $2.1M - Stock Titan
Is Arcadia Biosciences Inc. stock overvalued by current metricsMarket Volume Summary & Momentum Based Trading Ideas - ulpravda.ru
Is Arcadia Biosciences Inc. stock trading at a premium valuationNew Guidance & Stock Market Timing Techniques - Улправда
Will Arcadia Biosciences Inc. stock attract more institutional investorsJuly 2025 Momentum & Weekly High Momentum Picks - Улправда
IPO Launch: Will Arcadia Biosciences Inc. stock attract more institutional investorsCPI Data & Technical Pattern Recognition Alerts - Улправда
Arcadia Biosciences, Inc.Common Stock (NQ: RKDA - FinancialContent
RKDA stock rises pre-market after company receives merger termination notice from Roosevelt Resources - MSN
Returns Recap: How Arcadia Biosciences Inc 17D stock benefits from digital adoptionQuarterly Market Summary & Fast Gaining Stock Reports - Bộ Nội Vụ
Arcadia Biosciences Q1 Earnings Preview - MSN
Buy Signal: How Arcadia Biosciences Inc 17D stock benefits from digital adoptionPortfolio Update Summary & Long-Term Growth Plans - moha.gov.vn
Arcadia Biosciences strategic review after merger termination - TipRanks
Arcadia Biosciences Terminates Securities Exchange Agreement With Roosevelt Resources - TradingView — Track All Markets
Arcadia Biosciences stockholders back directors and governance moves - MSN
Arcadia Biosciences stock rises after Roosevelt terminates merger deal By Investing.com - Investing.com Australia
Health Care Stocks Recover In Late Trade -- Health Care Roundup - MarketScreener
Arcadia Biosciences (RKDA) Faces Terminated Agreement, Eyes Stra - GuruFocus
The Great Decoupling: Arcadia Biosciences and Roosevelt Resources Terminate High-Stakes Merger - FinancialContent
RKDA Stock Rises Pre-Market After Company Receives Merger Termination Notice From Roosevelt Resources - MenaFN
RKDA Stock Edges Lower After Company Receives Merger Termination Notice From Roosevelt Resources - Stocktwits
Arcadia Biosciences, Roosevelt Resources Terminate Business Combination Agreement - marketscreener.com
Roosevelt Resources terminates merger agreement with Arcadia Biosciences - Investing.com
Arcadia Biosciences stock rises after Roosevelt terminates merger deal - Investing.com
Roosevelt Resources terminates merger agreement with Arcadia Biosciences By Investing.com - Investing.com Australia
Arcadia Biosciences, Inc. Announces Termination of Securities Exchange Agreement with Roosevelt Resources, LP - Quiver Quantitative
Arcadia Biosciences receives termination notice of the proposed business combination with Roosevelt Resources - marketscreener.com
Arcadia Biosciences (RKDA) Receives Termination Notice of - GlobeNewswire
Revenue per share of Arcadia Biosciences, Inc. – GETTEX:17D - TradingView — Track All Markets
Street Watch: Will Arcadia Biosciences Inc stock attract more institutional investors2025 Price Targets & Precise Buy Zone Identification - moha.gov.vn
Arcadia Biosciences Stockholders Back Directors and Governance Moves - TipRanks
Published on: 2025-12-21 02:32:46 - Улправда
What dividend safety score for Arcadia Biosciences Inc. stockJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - Улправда
Can Arcadia Biosciences Inc. stock hit record highs again2025 Key Highlights & AI Powered Market Entry Ideas - Улправда
Can Arcadia Biosciences Inc. stock deliver strong Q4 earnings2025 Price Action Summary & Weekly Sector Rotation Insights - Улправда
S P Trends: How Arcadia Biosciences Inc. stock performs in high volatility marketsJuly 2025 Update & Consistent Profit Trade Alerts - DonanımHaber
Sentiment Watch: Is Arcadia Biosciences Inc. stock overvalued by current metrics2025 Fundamental Recap & Accurate Technical Buy Alerts - DonanımHaber
Will Arcadia Biosciences Inc. stock benefit from automationQuarterly Portfolio Review & Comprehensive Market Scan Insights - Улправда
How Low Can Arcadia Biosciences Stock Really Go? - Trefis
Can Arcadia Biosciences Inc. (17D) stock sustain double digit ROE2025 Macro Impact & Weekly Return Optimization Plans - Улправда
Ideas Watch: Can Arcadia Biosciences Inc. stock hit record highs againJuly 2025 Retail & Reliable Trade Execution Plans - Улправда
Is Arcadia Biosciences Inc. stock a dividend growth opportunityJuly 2025 PostEarnings & Real-Time Chart Pattern Alerts - Улправда
Foghorn Therapeutics (NASDAQ:FHTX) vs. Arcadia Biosciences (NASDAQ:RKDA) Head to Head Analysis - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Shares Cross Below Fifty Day Moving Average – Here’s Why - Defense World
Can Arcadia Biosciences Inc. stock sustain free cash flow growthWeekly Investment Report & Weekly Hot Stock Watchlists - Newser
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Arcadia Biosciences Inc Stock (RKDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Feb 03 '25 |
Buy |
2.49 |
700 |
1,743 |
2,819 |
0.17%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):